← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aeras
Rockville, MD
$3,158,494
Total funding
6
Grants
Funding over time
peak $1M · FY2006–18$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,215,044 · 4
CDC$1,090,500 · 1
FDA$852,950 · 1
By mechanism
U10$1,090,500 · 1
R01$993,044 · 2
U18$852,950 · 1
U01$210,000 · 1
R13$12,000 · 1
Investigators at Aeras
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Community-Based Sites for Evaluation of New TB Vaccines$873,500
U10 · FY2006 · PS
Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C$619,046
R01 · FY2012 · AI
Discovery of Biological and Immunological Biomarkers for TB Vaccines$362,102
U18 · FY2010 · FD
Discovery of Biological and Immunological Biomarkers for TB Vaccines$299,525
U18 · FY2012 · FD
Community-Based Sites for Evaluation of New TB Vaccines$217,000
U10 · FY2007 · PS
MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa$210,000
U01 · FY2017 · AI
Discovery of Biological and Immunological Biomarkers for TB Vaccines$191,323
U18 · FY2011 · FD
Optimization of Salmonelle-HIV-1 DNA Vaccine Vectors$147,883
R01 · FY2006 · AI
Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C$131,388
R01 · FY2011 · AI
Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C$94,727
R01 · FY2010 · AI
5th Global Forum on TB Vaccines$12,000
R13 · FY2018 · AI